Cite
MLA Citation
M Carrillo Palau et al.. “P437 Early therapeutic drug monitoring of Adalimumab, but not HLADQ*A1 determination, predicts inflammatory bowel disease outcome.” Journal of Crohn's and colitis, vol. 17, n.d., p. i566. http://access.bl.uk/ark:/81055/vdc_100179843904.0x000014